ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025
Early Prediction Model for Osteoporotic Fracture in Type 2 Diabetes Patients: A Nomogram Approach Based on a Single-Center Retrospective Study.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To address the high disability and mortality rates of osteoporotic fracture (OPF), a common complication of type 2 diabetes mellitus (T2DM), this study seeks to create an early OPF risk prediction model for T2DM patients. Methods: A single-center retrospective study was conducted on 868 T2DM patients using Multi-dimensional data. The dataset was split into training and validation sets at an 8:2 ratio. Through logistic regression analyses, key predictive factors were pinpointed and incorporated into a Nomogram prediction model. The model's reliability, validity, and generalizability were assessed using various statistical methods, including the Hosmer-Lemeshow test, Receiver Operator Characteristic (ROC) curve analysis, and decision curve analysis. The validation set was used to test the model. Results: Female gender (OR 2.681, 95% CI 1.046-6.803, P=0.04), age (OR 1.068, 95% CI 1.023-1.115, P=0.003), body mass index (BMI) (OR 0.912, 95% CI 0.851-0.979, P=0.010), blood lactic acid level (OR 0.747, 95% CI 0.597-0.935, P=0.011), lumbar T-score (OR 0.644, 95% CI 0.499-0.833, P=0.001), and femoral neck T-score (OR 0.412, 95% CI 0.292-0.602, P<0.001) were identified as independent factors predicting OPF in T2DM patients. Based on these factors, a Nomogram model was constructed. The model showed a high degree of agreement with actual data (Hosmer-Lemeshow test, P=0.406), with an Area Under the Curve (AUC) value of 0.831. It demonstrated good clinical benefits across different thresholds and excellent generalization ability on the validation set. Conclusion: This study integrated key factors such as gender, age, BMI, lactic acid, lumbar spine, and femoral neck T-values to construct a Nomogram for predicting the risk of OPF in T2DM patients. This model can assist doctors in accurately assessing the risk of OPF in T2DM patients, facilitating early detection and timely treatment. It has significant clinical practical value.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.